Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Sailong Pharmaceutical Group Co., Ltd. (002898.SZ)
Zhuhai, CN
Sailong Pharmaceutical Group Co., Ltd. is a comprehensive Chinese pharmaceutical company dedicated to the research, development, manufacturing, sales, and service of pharmaceutical intermediates, active pharmaceutical ingredients, and finished drug preparations. The firm's extensive product portfolio features compounds such as esomeprazole sodium, ornithine aspartate, thymus extracts, argatroban, gaicycline, monosialotetrahexose ganglioside sodium, cerebroprotein hydrolysate, milrinone, parecoxib sodium, tranexamic acid, clindamycin phosphate, and pantoprazole sodium. These offerings address a broad spectrum of medical needs, including cardiovascular, cerebrovascular, and neurological disorders, digestive system ailments, as well as acting as proton pump inhibitors, anti-infectives, anti-bleeding medications, and pain relievers, among other therapeutic applications. Established in 2002, the company is headquartered in Zhuhai, China. It operated as Zhuhai Sailong Pharmaceutical Co., Ltd. until September 2021, when it adopted its present name.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 002898.SZ
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
